Browsing: Recursion Pharmaceuticals

Artificial intelligence is rapidly transforming the field of drug discovery, with companies like Lila Sciences and Recursion Pharmaceuticals leading the way. These companies are leveraging AI scaling laws and building platforms that can accelerate the identification of new treatments and reshape scientific exploration.

Ben Taylor, CFO of Recursion Pharmaceuticals, discusses the rise of AI in biopharma, the importance of commitment in partnerships, and the challenges of data usage.